Chester County News and Community Website
MALVERN, PA — Phlexglobal, a leading innovative technology and services provider for the life sciences industry, recently announced its substantial contribution to COVID-19 clinical trial activities. Since the outbreak of …
Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat the whole eye, today announced the decision to discontinue the …
Read More
BERWYN, PA — Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company addressing Alzheimer’s (AD) , Parkinson’s (PD) and other neurodegenerative diseases, was awarded a $1.7 million grant from …
Read More
WASHINGTON, D.C. — This is a pivotal time in the field of gene therapy as the FDA continues its efforts to support innovators developing new medical products for Americans and …
Read More
MALVERN, PA — Reaction Biology Corporation (“RBC”), a leading contract research organization providing early-stage drug discovery services, announced that it has received a subcontract from Leidos Biomedical Research, Inc., which …
Read More
EXTON, PA — Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that EB Research Partnership, Inc. …
Read More
EXTON, PA — Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the U.S. Food and Drug …
Read More
EXTON, PA — Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that John Maslowski, President and Chief …
Read More
EXTON, PA — Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, provided an update on the interim results and progress …
Read More